China SXT Pharmaceuticals (China SXT Pharmaceuticals) Long-Term Capital Lease Obligation : $0.21 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Long-Term Capital Lease Obligation?

China SXT Pharmaceuticals's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.21 Mil.

China SXT Pharmaceuticals's quarterly Long-Term Capital Lease Obligation increased from Sep. 2022 ($0.00 Mil) to Mar. 2023 ($0.25 Mil) but then declined from Mar. 2023 ($0.25 Mil) to Sep. 2023 ($0.21 Mil).

China SXT Pharmaceuticals's annual Long-Term Capital Lease Obligation stayed the same from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.00 Mil) but then increased from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($0.25 Mil).

China SXT Pharmaceuticals Long-Term Capital Lease Obligation Historical Data

The historical data trend for China SXT Pharmaceuticals's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Long-Term Capital Lease Obligation Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.25

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial									-	-	-	0.25	0.21

China SXT Pharmaceuticals (NAS:SXTC) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

China SXT Pharmaceuticals Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.